The UAE’s In-Vitro Fertilization (IVF) sector is expected to command a market value of $1.5 billion by 2020, according to a new study carried by IVI Middle East.
The IVF global market will cross $27 billion by 2020, the study said.
The overall Middle East IVF market will be worth $1.01 billion in 2017, registering a growth of 11.8 per cent compared with last year, said the international medical centre that has main regional headquarter in Abu Dhabi along with branches in Dubai and Muscat.
"Changing lifestyle conditions; reduced ovarian reserve in women, delayed pregnancy, gynecological conditions and fertility disorders are some of the major factors that drive the market growth," said Dr Human Fatemi, medical director at IVI Middle East.
Commenting on the evolving market, he added: "Infertility is one of commonly encountered medical conditions in the Middle East. According to various reports, it has been estimated that infertility affects 15 per cent of the global population of reproductive age, but this percentage is even higher in the Middle East. This has paved way for the industry to experience growth in the region."
Statistics revealed by IVI Middle East Fertility Clinic suggest that Intra-cytoplasmic Sperm Injection (ICSI) has contributed to over 98 per cent of successful pregnancies for the clinic in the last one year.
The innovative and customised treatment approach at IVI clinics backed by strong research on infertility causing factors in the region has delivered over 70 per cent success rate in the Middle East, much higher than the clinic’s success rates in other parts of the world.